Paper Details

  1. Home
  2. Paper Details

Bambuterol: clinical effects of three doses of bambuterol once daily in asthmatic patients.

Author: ClemmensenI H, LaursenL C, PedersenB K, RavnS, WeekeB

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Bambuterol, a terbutaline pro-drug, was effective in treating asthma in 22 patients. The dose of 0.270 mg/kg was preferable, with no significant side effects observed.
Paper Details　
Original Abstract of the Article :
Twenty-two asthmatics received bambuterol solution, a terbutaline pro-drug, once every evening. The following doses were each given orally for 7 days in a double-blind cross-over study: 0.185, 0.270 and 0.400 mg/kg. Bambuterol 0.270 mg/kg was preferable regarding clinical effects and side effects. T...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/j.1398-9995.1988.tb00929.x

データ提供：米国国立医学図書館（NLM）

Bambuterol: A Dose-Dependent Oasis for Asthma

Asthma, a condition that feels like a sandstorm in the lungs, can disrupt breathing and quality of life. Researchers are constantly seeking new and effective treatments, like searching for hidden oases in the desert. This study explores the effectiveness of bambuterol, a long-acting bronchodilator, in treating asthma.

The researchers investigated the effects of different doses of bambuterol in asthmatic patients. They found that a specific dose, 0.270 mg/kg, provided the most effective relief from asthma symptoms while minimizing side effects. This is a significant discovery, like finding a well-placed oasis that provides optimal relief and hydration.

Bambuterol: A Dose-Dependent Path to Relief

The study suggests that bambuterol, at the right dose, can effectively manage asthma symptoms. This is encouraging news, like finding a well-marked path through the desert that leads to improved breathing and a better quality of life.

A More Breathable Future for Asthma Sufferers

This study provides a valuable roadmap for treating asthma. By finding the optimal dose of bambuterol, physicians can help patients find relief from their symptoms and navigate the desert of asthma with greater ease. This discovery, like finding a reliable spring in the desert, offers hope for a more breathable future for asthma sufferers.

Dr.Camel's Conclusion

This research highlights the importance of finding the right dose for optimal treatment outcomes. Bambuterol, a long-acting bronchodilator, shows promise for managing asthma symptoms, offering a potential oasis of relief for sufferers. This discovery, like finding a hidden spring that provides a refreshing source of water, could lead to a more comfortable and manageable experience for those living with asthma.

Date :
  1. Date Completed 1989-02-07
  2. Date Revised 2019-08-20
Further Info :

Pubmed ID

3061311

DOI: Digital Object Identifier

10.1111/j.1398-9995.1988.tb00929.x

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.